Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Afr Health Sci ; 19(4): 3200-3207, 2019 Dec.
Article in English | MEDLINE | ID: mdl-32127897

ABSTRACT

INTRODUCTION: Pneumocystis jirovecii is the causative organism of Pneumocystis pneumonia (PCP) in humans, which is more common among immunocompromised patients. Classically patients present with fever, non-productive cough, and dyspnoea. In the HIV-infected individuals the symptoms may be subtle at first, but gradually progress over several weeks. In the HIV-uninfected patient, however, the duration of symptoms is shorter and more severe, mainly due to the increased inflammatory response of the HIV-uninfected patient. METHODS: This article focuses on the diagnostic methods and then the management and prophylaxis principles of PCP by reviewing the best current practices and guidelines in Africa. CONCLUSION: This overview is presented by clinicians who have experience with PCP and is directed mainly at first-line healthcare providers.


Subject(s)
Anti-Bacterial Agents/standards , Anti-Bacterial Agents/therapeutic use , General Practitioners/education , Immunocompromised Host , Pneumonia, Pneumocystis/diagnosis , Pneumonia, Pneumocystis/drug therapy , Practice Guidelines as Topic , Adult , Africa/epidemiology , Aged , Aged, 80 and over , Female , HIV Infections/complications , Humans , Male , Middle Aged , Pneumocystis carinii/isolation & purification , Pneumonia, Pneumocystis/epidemiology , Symptom Assessment/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...